Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
12:42pm, Thursday, 14'th Aug 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) investors concernin
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) on behalf of investors concer
TNDM Stock Falls on Q2 Earnings Miss, Revenues Beat, Gross Margin Up
08:55am, Monday, 11'th Aug 2025
Tandem Diabetes posts record Q2 sales and higher margins, but earnings miss sends shares tumbling 20%.
Top 3 Health Care Stocks That Are Preparing To Pump This Month
08:01am, Monday, 11'th Aug 2025
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Tandem Diabetes Care: An Earnings Miss Confirms The Bear Case - Downgrade To Sell
07:30am, Sunday, 10'th Aug 2025
Downgrading Tandem Diabetes Care to sell after Q2 2025 earnings confirms core U.S. business weakness and deteriorating profitability. Intense competition from Insulet and Medtronic is eroding Tandem's
Tandem Diabetes Care issues voluntary device correction for certain insulin pumps
09:32am, Thursday, 07'th Aug 2025
Tandem Diabetes Care issued a voluntary correction for an insulin pump model due to a speaker malfunction that disrupts communication with glucose monitoring systems, potentially causing high blood su
Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps
08:30am, Thursday, 07'th Aug 2025
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker-related issu
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Thursday.
Tandem Diabetes Care, Inc. (TNDM) Q2 2025 Earnings Call Transcript
02:00am, Thursday, 07'th Aug 2025
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants John F. Sheridan - President, CEO & Director Leigh A.
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say
08:01pm, Wednesday, 06'th Aug 2025
The headline numbers for Tandem Diabetes Care (TNDM) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Str
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates
06:51pm, Wednesday, 06'th Aug 2025
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.47 per share a year ago.
Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance
04:05pm, Wednesday, 06'th Aug 2025
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 20
Bears are Losing Control Over Tandem Diabetes Care (TNDM), Here's Why It's a 'Buy' Now
10:56am, Tuesday, 05'th Aug 2025
Tandem Diabetes Care (TNDM) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement
Tandem Diabetes Care Announces Upcoming Conference Participation
04:05pm, Thursday, 31'st Jul 2025
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a comp
Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Wednesday, 30'th Jul 2025
Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
